Instituto de Investigación Sanitaria La Fe
Contact information
Instituto de Investigación Sanitaria La Fe
Silvia Sánchez
Avenida Fernando Abril Martorell, 106 - Hospital La Fe, Torre A, Planta 7ª
Valencia
Valencia
961246609
Areas of activities
- A. Health Biotechnology
- Areas of activity
- Biomarkers
- Stem cells
- Cell cultures
- Medical devices
- Drug discovery
- Screening
- Cellular Therapy
- Gene Therapy
- Biomaterials and tissue therapy
- Transplant
- Therapeutic areas
- Substance abuse
- Analgesia & Pain
- Dermatology
- Musculoskeletal system
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Infectious diseases
- Inflammatory diseases
- Gynaecology and obstetrics
- Oncology
- Blood and lymphatic system
- Digestive system and hepatology
- Kidney and genitourinary system
- Central nervous system
- Respiratory and pulmonary system
- Metabolic disorders / Endocrinology
- B. Agrifood Biotechnology
- Food
- Functional Food
- Vitamins and nutrition products
- D. Services
- R&D services
- Pharmacogenomics
- Genomics
- Metabolomics
- Nanotechnology and in silico biology
- CRO / CMO / SMO
- Professional services
Commissions
IIS La Fe's mission is to promote and develop translational research and innovation in health, of proven quality and excellence, sustainable and oriented to the resolution of health problems, contributing to scientific, formative and economic development, and to the improvement of the quality of life of the society.
Products and services
The priority research areas of IIS La Fe are:
- Advanced Therapies
- Translational research of prevalent diseases and their mechanisms
- Oncology and Oncohematology
- Reproductive Medicine, Perinatology and Child Health
- Safety in the development and use of medicines
- New technologies applied to health
- Assistance, preventive and sustainable care
Biotech Sanitaria
| Product / Service | Type | Development phase |
|---|---|---|
| Biolectronics, Signal Processing and Algorithmy Unit | Other | R&D |
| Analytical Unit certified GLP | Screening/Drug Discovery | Clinical Validation |
| Epigenomics Unit | Screening/Drug Discovery | Preclinical |
| Genomic Unit | Screening/Drug Discovery | R&D |
| Cytomics Unit | Screening/Drug Discovery | R&D |
| Biotechnology platform | Enabling Technologies, Screening/Drug Discovery | R&D |
| Platform for Health ICT | Enabling Technologies | Preclinical |
| Microscopy | Enabling Technologies | R&D |
| Data Science, Biostatistics and Bioinformatic Unit | Enabling Technologies | R&D |
| Pharmacogenetics | Enabling Technologies | R&D |
| Innovative drugs | Enabling Technologies | R&D |
| Biomarkers Platform: MR imaging acquisition | Enabling Technologies | R&D |
| Advanced Therapies Unit | CMO, CRO, Drug Delivery | Registration |
| Clinical and Products with Biological Activity Research Unit (UICAB) | CMO, CRO | Registration |
| Biobank | CRO, CMO | R&D |
| Animal experimentation capabilities | CRO, CMO | R&D |
| Product / Service | Type | Therapeutic area | Development phase |
|---|---|---|---|
| Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy | Biomarkers, Diagnostic | Oncología, Enfermedades cardiovasculares y sistema circulatorio | Preclinical |
| Method for predicting response to continuous positive air pressure treatment | Diagnostic | Sistema respiratorio y pulmonar | R&D |
| miRNA based Diagnostic method for bladder cancer | Biomarkers, Diagnostic | Oncología | Preclinical |
| Composition comprising oxylipins present in human milk derived small extracellular vesicles and its use in the prevention and treatment of intestinal diseases | Biomarkers, Diagnostic | Sistema digestivo y hepatología | R&D |
| Determination of autoantibodies in autoimmune patients Ro/SSA+ | Biomarkers, Diagnostic | Inmunología | R&D |
| Biomarkers predictive of cardiac ischemia risk | Biomarkers, Diagnostic | Enfermedades cardiovasculares y sistema circulatorio | Preclinical |
| Product / Service | Type | Therapeutic area | Development phase |
|---|---|---|---|
| Sensorised continuous monitoring brace | Medical devices | Desórdenes musculoesqueléticos | R&D |
| New medical device for the endoscopic treatment of post-surgical fistulas | Medical devices | R&D | |
| Prostate palpation device | Medical devices | Oncología | Preclinical |